Patents by Inventor Geert Berx

Geert Berx has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METAGENE EXPRESSION SIGNATURE FOR PROGNOSIS OF BREAST CANCER PATIENTS
    Publication number: 20130324438
    Abstract: Described are gene expression signatures able to distinguish individuals having or suspected to have breast cancer with good clinical prognosis from individuals with poor clinical prognosis, based on ZEB2 transcriptional activity. Further described are kits and assays related to the prognosis and/or the change in prognosis of the individuals suffering from breast cancer.
    Type: Application
    Filed: October 31, 2011
    Publication date: December 5, 2013
    Inventors: Geert Berx, Eric Raspe
  • MINICHROMOSOME MAINTENANCE COMPLEX INTERACTING PROTEIN INVOLVED IN CANCER
    Publication number: 20110229491
    Abstract: The present invention relates to a protein that is interacting with the minichromosome maintenance complex in eukaryotes. More specifically, the invention relates to the use of a protein, interacting with the minichromosome complex, and the gene encoding this protein in diagnosis, prognosis and treatment of cancer.
    Type: Application
    Filed: May 29, 2009
    Publication date: September 22, 2011
    Inventors: Lieven De Veylder, Geert Berx, Naoki Takahashi, Mauricio Quimbaya, Eric Raspe
  • USE OF SIP1 AS DETERMINANT OF BREAST CANCER STEMNESS
    Publication number: 20110104183
    Abstract: The present invention relates to the diagnosis and treatment of cancer. More specifically, it relates to the use of SIP1 nucleic acid and/or protein for the detection of breast cancer stem cells, and the repression of the gene and/or the inactivation of the protein to repress the differentiation of cells into cancer cells and to inhibit metastasis of breast cancer tumors.
    Type: Application
    Filed: February 26, 2009
    Publication date: May 5, 2011
    Applicants: VIB VZW, UNIVERSITEIT GENT
    Inventors: Geert Berx, Cindy Vandewalle, Eric Raspe
  • Method to control tumor progression and invasiveness
    Patent number: 7569668
    Abstract: Described is a method of modulating E-cadherin mediated cell adhesion. More specifically, described is the use of hECRep1a and homologues thereof to modulate and/or control tumor cell invasiveness.
    Type: Grant
    Filed: June 16, 2006
    Date of Patent: August 4, 2009
    Assignees: Vlaams Interuniversitair Instituut Voor Biotechnologie VZW, Universiteit Gent
    Inventors: Frans Van Roy, Geert Berx, Kristin Strumane
  • Method to control tumor progression and invasiveness
    Publication number: 20070066803
    Abstract: Described is a method of modulating E-cadherin mediated cell adhesion. More specifically, described is the use of hECRep1a and homologues thereof to modulate and/or control tumor cell invasiveness.
    Type: Application
    Filed: June 16, 2006
    Publication date: March 22, 2007
    Applicants: Vlaams Interuniversitair Instituut Voor Biotechnologie VZW, Universiteit Gent
    Inventors: Frans Roy, Geert Berx, Kristin Strumane
  • Method to control tumor progression and invasiveness
    Publication number: 20050089896
    Abstract: Described is a method of modulating E-cadherin mediated cell adhesion. More specifically, described is the use of hECRep1a and homologues thereof to modulate and/or control tumor cell invasiveness.
    Type: Application
    Filed: August 20, 2004
    Publication date: April 28, 2005
    Inventors: Frans Roy, Geert Berx, Kristin Strumane